News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
611,506 Results
Type
Article (47061)
Company Profile (241)
Press Release (564204)
Section
Business (172724)
Career Advice (1719)
Deals (30728)
Drug Delivery (96)
Drug Development (72270)
Employer Resources (134)
FDA (15575)
Job Trends (14056)
News (298705)
Policy (30170)
Tag
Academia (2671)
Alliances (43021)
Alzheimer's disease (1198)
Approvals (15541)
Artificial intelligence (152)
Bankruptcy (268)
Best Places to Work (11398)
Biotechnology (178)
Breast cancer (189)
Cancer (1370)
Cardiovascular disease (112)
Career advice (1445)
Cell therapy (279)
Clinical research (57912)
Collaboration (475)
Compensation (241)
COVID-19 (2437)
C-suite (113)
Data (1386)
Diabetes (171)
Diagnostics (5853)
Earnings (66835)
Employer resources (119)
Events (93399)
Executive appointments (396)
FDA (16263)
Funding (408)
Gene therapy (193)
GLP-1 (608)
Government (4457)
Healthcare (18972)
Infectious disease (2523)
Inflammatory bowel disease (119)
Interviews (272)
IPO (14593)
Job creations (3108)
Job search strategy (1268)
Layoffs (342)
Legal (6557)
Lung cancer (203)
Lymphoma (97)
Manufacturing (188)
Medical device (13862)
Medtech (13866)
Mergers & acquisitions (16349)
Metabolic disorders (458)
Neuroscience (1509)
NextGen Class of 2024 (6384)
Non-profit (4377)
Northern California (1653)
Obesity (264)
Opinion (194)
Patents (110)
People (50965)
Phase I (17682)
Phase II (25433)
Phase III (19563)
Pipeline (495)
Postmarket research (2350)
Preclinical (7324)
Radiopharmaceuticals (245)
Rare diseases (256)
Real estate (4846)
Regulatory (20587)
Research institute (2367)
Resumes & cover letters (260)
Southern California (1363)
Startups (3260)
United States (14601)
Vaccines (534)
Weight loss (192)
Date
Today (2)
Last 7 days (245)
Last 30 days (2125)
Last 365 days (34187)
2024 (34108)
2023 (38815)
2022 (49630)
2021 (53738)
2020 (51988)
2019 (45393)
2018 (34224)
2017 (30334)
2016 (29104)
2015 (33855)
2014 (25527)
2013 (21192)
2012 (22823)
2011 (23369)
2010 (22064)
Location
Africa (729)
Arizona (156)
Asia (36826)
Australia (6399)
California (3634)
Canada (1353)
China (293)
Colorado (181)
Connecticut (186)
Europe (82286)
Florida (510)
Georgia (129)
Illinois (374)
Indiana (225)
Maryland (645)
Massachusetts (2896)
Michigan (130)
Minnesota (277)
New Jersey (1069)
New York (1005)
North Carolina (798)
Northern California (1653)
Ohio (131)
Pennsylvania (861)
South America (1036)
Southern California (1363)
Texas (531)
Utah (109)
Washington State (386)
611,506 Results for "nu med plus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
November 4, 2024
·
7 min read
BioMidwest
Nu-Tek BioSciences Inks Deal with IMCD for Distribution – Expands Global Reach in Europe & APAC Regions
Nu-Tek BioSciences is an innovative manufacturer of critical raw materials used in cell culture media for the development and manufacturing of pharmaceuticals.
June 4, 2024
·
3 min read
Business
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine),
March 21, 2024
·
2 min read
Press Releases
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy
November 6, 2024
·
3 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
BioMidwest
Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
VolitionRx Limited has announced that its Nu.Q® Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech, a leading veterinary diagnostics company.
April 23, 2024
·
6 min read
Business
Nu Skin Enterprises Appoints Mark A. Zorko to Board of Directors
September 12, 2024
·
2 min read
Drug Development
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)
Moleculin Biotech, Inc. today announced the commencement of an Investigator-initiated Phase 2 study evaluating WP1066 in combination with radiation therapy for the treatment of adults with glioblastoma (NU 21C06) in cooperation with the Company.
May 15, 2024
·
6 min read
BioMidwest
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
VolitionRx Limited has agreed a supply agreement with Fujifilm Vet Systems Co. Ltd, a leading veterinary diagnostic laboratory service, to launch the Nu.Q® Vet Cancer Test to veterinarians in Japan.
March 20, 2024
·
6 min read
FDA Grants Clearance to Gel4Med: Breakthroughs in Wound Management with G4Derm and G4Derm Plus
Gel4Med, an innovative biomaterials company, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its first biosynthetic matrix products, G4Derm and G4Derm Plus.
October 23, 2023
·
3 min read
1 of 61,151
Next
